Medication and Dietary Supplement Interactions among a Low-Income, Hospitalized Patient Population Who Take Cardiac Medications

Abstract EN

Purpose.

To identify characteristics associated with the use of potentially harmful combinations of dietary supplements (DS) and cardiac prescription medications in an urban, underserved, inpatient population.

Methods.

Cardiac prescription medication users were identified to assess the prevalence and risk factors of potentially harmful dietary supplement-prescription medication interactions (PHDS-PMI).

We examined sociodemographic and clinical characteristics for crude (χ2 or t-tests) and adjusted multivariable logistic regression associations with the outcome.

Results.

Among 558 patients, there were 121 who also used a DS.

Of the 110 participants having a PHDS-PMI, 25% were asked about their DS use at admission, 75% had documentation of DS in their chart, and 21% reported the intention to continue DS use after discharge.

A multivariable logistic regression model noted that for every additional medication or DS taken the odds of having a PHDS-PMI increase and that those with a high school education are significantly less likely to have a PHDS-PMI than those with a college education.

Conclusion.

Inpatients at an urban safety net hospital taking a combination of cardiac prescription medications and DS are at a high risk of harmful supplement-drug interactions.

Providers must ask about DS use and should consider the potential for interactions when having patient discussions about cardiac medications and DS.